scholarly journals In vivo Performance of Biodegradable Calcium Phosphate Glass Ceramics using the Rabbit Model: Histological and SEM Observation

2006 ◽  
Vol 20 (3) ◽  
pp. 253-266 ◽  
Author(s):  
A. G. Dias ◽  
M. A. Lopes ◽  
J. D. Santos ◽  
A. Afonso ◽  
K. Tsuru ◽  
...  
Author(s):  
Seong Ho Choi ◽  
D.H. Baik ◽  
C.S. Kim ◽  
Chong Kwan Kim ◽  
Kyoung Nam Kim ◽  
...  

Author(s):  
Godday Anebow Lulu ◽  
Arunkumar Karunanidhi ◽  
Loqman Mohamad Yusof ◽  
Yusuf Abba ◽  
Fazlin Mohd Fauzi ◽  
...  

2000 ◽  
Vol 192-195 ◽  
pp. 223-226 ◽  
Author(s):  
Toshihiro Kasuga ◽  
Masayuki Nogami ◽  
Mitsuo Niinomi

2007 ◽  
Vol 330-332 ◽  
pp. 165-168
Author(s):  
Hyun Ju Moon ◽  
Racquel Z. LeGeros ◽  
Kyoung Nam Kim ◽  
Kwang Mahn Kim ◽  
Seong Ho Choi ◽  
...  

The purpose of this study was to compare the bone regenerative effect of calcium phosphate glass according to the particle size in vivo. We prepared two different sizes, that is 400 μm and 40 μm, of calcium phosphate glass powder using the system CaO-CaF2-P2O5-MgO-ZnO. Critical-sized calvarial defects were created in 60 male Sprague-Dawley rats. The animals were divided into 3 groups of 20 animals each. Each defect was filled with a constant weight of 0.5 g calcium phosphate glass powder mixed with saline. As controls, the defect was left empty. The rats were sacrificed 2 or 8 weeks after postsurgery, and the results were evaluated using histological as well as histomorphometrical studies. The particle size of the calcium phosphate was crucial; 400 μm particles promoted new bone formation, while 40 μm particles inhibited it because of severe inflammation.


2014 ◽  
Vol 20 (1) ◽  
pp. 135-140 ◽  
Author(s):  
Tae Wan Kim ◽  
Su Chak Ryu ◽  
Byung Kyu Kim ◽  
Seog Young Yoon ◽  
Hong Chae Park

2001 ◽  
Vol 16 (3) ◽  
pp. 876-880 ◽  
Author(s):  
Toshihiro Kasuga ◽  
Miwako Terada ◽  
Masayuki Nogami ◽  
Mitsuo Niinomi

Glass-ceramics containing a large amount of calcium pyrophosphate (β–Ca2P2O7) crystal were prepared via crystallization and sintering; compacts of a calcium phosphate glass powders with a composition of 60CaO · 30P2O5 · 5TiO2 · 5Na2O (in mol%) were heated for 3–6 h at 850 °C in air. The compacts were densified by the viscous flow of the glassy phases during heating. The calcium phosphate glass-ceramics were found to show a bending strength of approximately 100 MPa, and they were easy to machine, as confirmed by a drilling test using a conventional carbide tool. The machinability is thought to arise from the microstructure consisting predominantly of the interlocking and platelike β–Ca2P2O7 precipitated in the glass.


2007 ◽  
Vol 19 (3) ◽  
pp. 1097-1108 ◽  
Author(s):  
Ahmed Soltan Monem ◽  
Hatem A. ElBatal ◽  
Elsayed M. A. Khalil ◽  
Moenis A. Azooz ◽  
Yousry M. Hamdy

2019 ◽  
Vol 8 (6) ◽  
pp. 266-274
Author(s):  
I. Palmer ◽  
S. A. Clarke ◽  
F. J Buchanan

Objectives Bioresorbable orthopaedic devices with calcium phosphate (CaP) fillers are commercially available on the assumption that increased calcium (Ca) locally drives new bone formation, but the clinical benefits are unknown. Electron beam (EB) irradiation of polymer devices has been shown to enhance the release of Ca. The aims of this study were to: 1) establish the biological safety of EB surface-modified bioresorbable devices; 2) test the release kinetics of CaP from a polymer device; and 3) establish any subsequent beneficial effects on bone repair in vivo. Methods ActivaScrew Interference (Bioretec Ltd, Tampere, Finland) and poly(L-lactide-co-glycolide) (PLGA) orthopaedic screws containing 10 wt% β-tricalcium phosphate (β-TCP) underwent EB treatment. In vitro degradation over 36 weeks was investigated by recording mass loss, pH change, and Ca release. Implant performance was investigated in vivo over 36 weeks using a lapine femoral condyle model. Bone growth and osteoclast activity were assessed by histology and enzyme histochemistry. Results Calcium release doubled in the EB-treated group before returning to a level seen in untreated samples at 28 weeks. Extensive bone growth was observed around the perimeter of all implant types, along with limited osteoclastic activity. No statistically significant differences between comparative groups was identified. Conclusion The higher than normal dose of EB used for surface modification did not adversely affect tissue response around implants in vivo. Surprisingly, incorporation of β-TCP and the subsequent accelerated release of Ca had no significant effect on in vivo implant performance, calling into question the clinical evidence base for these commercially available devices. Cite this article: I. Palmer, S. A. Clarke, F. J Buchanan. Enhanced release of calcium phosphate additives from bioresorbable orthopaedic devices using irradiation technology is non-beneficial in a rabbit model: An animal study. Bone Joint Res 2019;8:266–274. DOI: 10.1302/2046-3758.86.BJR-2018-0224.R2.


Sign in / Sign up

Export Citation Format

Share Document